Ex-vivo tests: cosmetics without human testing
The cosmetic industry has faced a complete regulatory revolution in the last 20 years. The change from the European Directive to the Regulation in 2009, increasing the safety requirements for cosmetic products, centralizing the notification of all cosmetics products placed on the EU market or the introduction of a “responsible person” was a unique milestone for the cosmetics industry. The EU showed an increasing awareness of the products circulating on the European market and how are they produced and tested. The framework has naturally developed under the social pressure against animal testing, which was banned in the EU in 2013.
A global concern
The Animal testing ban has changed the behavior of both the industry and the customers. Nowadays other countries, including the U.S., are following the European lead. Not only ethical concerns but also increasing tendency inside the scientific community to disregard animal testing data as not being proved reliable are motivating these regulatory changes.
How to avoid it?
New methods using synthetic skin can provide the most accurate, less time-consuming answers for a new philosophy of producing cosmetic products. Consequently, the clinical trials’ failure rate can be drastically decreased and reduce the final cost of manufacturing through the application of these new techniques.
The Reconstructed Human Epidermis (RHE) test method is a good example of this new vision, using the same patron of the human skin copying its physiological and biochemical properties.
These methods will gradually become the best way to comply with the European legislation while also respecting the environmental and social responsibility. Obelis, as one of the most experienced companies of the sector, is ready to be part of your business success, guiding you through the new challenges – contact us to safeguard your products’ compliance with the European regulation!